SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
34.43
-2.69 (-7.25%)
At close: Apr 10, 2025, 4:00 PM
34.71
+0.28 (0.83%)
After-hours: Apr 10, 2025, 7:13 PM EDT
SpringWorks Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SpringWorks Therapeutics stock have an average target of 72.4, with a low estimate of 65 and a high estimate of 78. The average target predicts an increase of 110.28% from the current stock price of 34.43.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 24, 2025.
Analyst Ratings
The average analyst rating for SpringWorks Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +114.93% | Feb 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +114.93% | Feb 21, 2025 |
| Wedbush | Wedbush | Buy Reiterates $77 | Buy | Reiterates | $77 | +123.64% | Feb 12, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $60 → $65 | Buy | Maintains | $60 → $65 | +88.79% | Feb 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +114.93% | Feb 12, 2025 |
Financial Forecast
Revenue This Year
356.32M
from 191.59M
Increased by 85.98%
Revenue Next Year
602.76M
from 356.32M
Increased by 69.16%
EPS This Year
-2.43
from -3.48
EPS Next Year
-0.70
from -2.43
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 415.2M | 753.1M | 1.2B | ||
| Avg | 356.3M | 602.8M | 870.3M | ||
| Low | 316.5M | 448.8M | 681.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 116.7% | 111.3% | 97.1% | ||
| Avg | 86.0% | 69.2% | 44.4% | ||
| Low | 65.2% | 26.0% | 13.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.93 | 0.19 | 4.02 | ||
| Avg | -2.43 | -0.70 | 1.87 | ||
| Low | -2.75 | -2.00 | -0.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.